Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Heart disease in women worse than previously thought

22.03.2006


Angina, a common form of heart disease, is more dangerous for women than was previously thought, according to a new study published in the Journal of the American Medical Association (JAMA). The collaborative study, led by UCL (University College London) and funded by the British Heart Foundation, found that angina in women is as common as it is in men, in contrast to heart attacks (myocardial infarction) which have a higher rate in men. The findings suggest that the medical profession should pay more attention to thoroughly investigating and diagnosing women suspected of having angina.



UCL Professor Harry Hemingway and colleagues studied over 100,000 patients aged 45-89 years with angina using electronic health records. They found that each year, two women out of every 100 in the general population developed angina, as the first sign of heart disease. This makes angina much more common than heart attacks (the risks of which are usually measured per 1,000 population).

The study also found that for women, the diagnosis of angina is less frequently confirmed with tests, such as angiograms or treadmill exercise electrocardiograms. In the patients in the study, drug treatment aimed at relieving angina (nitrates) was prescribed solely on the basis of symptom history.


In the study, angina in women was also associated with increased death rates, where women diagnosed without the confirmatory test had significantly higher death rates from heart disease. Such women have often been dismissed as having a ‘soft’ subjective complaint, without real pathological changes in the heart. The study suggests that this attitude is incorrect.

Among women with angina and diabetes, the annual risk of a heart attack was particularly high and similar to the risk in men (about one in 10).

Professor Hemingway, from the UCL Department of Epidemiology and Public Health, says: “For women, angina is a more significant public health problem than many doctors, or indeed the general public, realise. Women develop angina at a similarly high rate as men. And the angina which women experience is not benign in terms of death rates. We need to understand why women are relatively protected from heart attack but not from angina, and ensure fair access to investigation and treatment services.

“Angina has been a Cinderella in heart disease research because of the difficulties in establishing which patients have angina – many people with symptoms are not tested – and because most patients are not hospitalised. The opposite is true for heart attacks, where nearly all patients are tested to confirm the diagnosis and are admitted as an emergency into hospital.”

Angina is a symptom of chest pain or discomfort which is brought on by exercise (or cold or emotional stress) and relieved by rest. These symptoms are due to the supply of oxygen to the heart muscle (myocardium) being insufficient to meet demand (so called myocardial ischaemia). Narrowing and hardening of the blood vessels which supply oxygen to the heart muscle causes angina. Atherosclerosis is the cause of the narrowing and hardening of the coronary (heart) arteries.

Angina is more likely to occur in people who have one or more of the following risk factors: older age, smoking, high blood pressure, high cholesterol, diabetes, obesity, family history.

Angina can be prevented by lifestyle changes (stopping smoking, increasing exercise) and by lowering blood pressure and cholesterol. The symptoms of angina can be relieved with medication (such as nitrates or beta-blockers) and by undergoing a coronary revascularisation procedure. The risk of having a heart attack after having experienced angina can be reduced by taking ‘secondary prevention’ medications such as aspirin and lipid lowering drugs. There is no cure for the underlying disease process of atherosclerosis.

Jenny Gimpel | alfa
Further information:
http://www.ucl.ac.uk

More articles from Health and Medicine:

nachricht New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery
12.11.2018 | Purdue University

nachricht Exosomes 'swarm' to protect against bacteria inhaled through the nose
12.11.2018 | Massachusetts Eye and Ear Infirmary

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

Im Focus: Nanorobots propel through the eye

Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.

Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

In focus: Peptides, the “little brothers and sisters” of proteins

12.11.2018 | Life Sciences

Materials scientist creates fabric alternative to batteries for wearable devices

12.11.2018 | Materials Sciences

A two-atom quantum duet

12.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>